XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -30.01%1.01B | -30.01%1.01B | 15.08%1.66B | 20.12%1.24B | 1.09%1.49B | -31.19%1.44B | -31.19%1.44B | -40.02%1.44B | 27.34%1.03B | -27.71%1.47B |
-Cash and cash equivalents | -31.04%933M | -31.04%933M | 20.88%1.64B | 29.50%1.24B | 14.87%1.48B | -30.90%1.35B | -30.90%1.35B | -41.15%1.36B | 32.04%956M | -33.32%1.29B |
-Short-term investments | -13.25%72M | -13.25%72M | -84.81%12M | -94.87%4M | -98.88%2M | -35.66%83M | -35.66%83M | -10.23%79M | -11.36%78M | 85.42%178M |
Receivables | ---- | ---- | 1.00%1.41B | 7.76%1.43B | 1.67%1.4B | 6.09%1.39B | 6.09%1.39B | -4.64%1.4B | -10.88%1.33B | 7.83%1.38B |
-Accounts receivable | ---- | ---- | 0.10%1.03B | 4.89%1.05B | 0.29%1.04B | -2.09%1.03B | -2.09%1.03B | -4.11%1.03B | -11.08%1B | -2.53%1.04B |
-Other receivables | ---- | ---- | 3.49%385M | 16.67%378M | 5.92%358M | 38.93%364M | 38.93%364M | -6.06%372M | -10.25%324M | 60.19%338M |
Inventory | ---- | ---- | -2.81%415M | -2.34%417M | 14.47%451M | 30.79%446M | 30.79%446M | 16.99%427M | 12.66%427M | 12.25%394M |
Other current assets | 1,565.14%1.82B | 1,565.14%1.82B | -1.06%93M | -26.02%91M | 18.26%136M | 0.93%109M | 0.93%109M | 18.99%94M | 18.27%123M | 18.56%115M |
Total current assets | -16.67%2.82B | -16.67%2.82B | 6.49%3.58B | 9.24%3.18B | 3.49%3.47B | -12.08%3.38B | -12.08%3.38B | -22.06%3.36B | 4.56%2.91B | -10.70%3.36B |
Non current assets | ||||||||||
Net PPE | 0.64%35.66B | 0.64%35.66B | 1.47%35.67B | 1.38%35.45B | 2.25%35.56B | 1.97%35.43B | 1.97%35.43B | 2.00%35.15B | 2.46%34.97B | 3.89%34.78B |
-Gross PPE | -29.83%35.66B | -29.83%35.66B | 4.81%52B | 4.26%51.57B | 4.57%51.17B | 4.54%50.82B | 4.54%50.82B | 2.85%49.61B | 3.19%49.47B | 3.90%48.93B |
-Accumulated depreciation | ---- | ---- | -12.94%-16.33B | -11.20%-16.12B | -10.30%-15.61B | -10.98%-15.39B | -10.98%-15.39B | -4.96%-14.46B | -5.01%-14.49B | -3.93%-14.15B |
Goodwill and other intangible assets | ---- | ---- | 6.88%544M | 4.70%535M | 4.00%520M | 0.80%506M | 0.80%506M | -5.21%509M | -8.26%511M | 10.38%500M |
-Goodwill | ---- | ---- | ---- | ---- | ---- | 1.88%325M | 1.88%325M | ---- | ---- | ---- |
-Other intangible assets | ---- | ---- | ---- | ---- | ---- | -1.09%181M | -1.09%181M | ---- | ---- | ---- |
Investments and advances | 5.13%2.52B | 5.13%2.52B | 5.12%2.49B | 5.00%2.46B | 4.80%2.42B | 4.58%2.4B | 4.58%2.4B | 3.28%2.36B | 3.82%2.34B | 7.93%2.31B |
Other non current assets | 156.69%1.77B | 156.69%1.77B | 70.60%795M | 52.16%738M | 35.61%716M | 31.80%688M | 31.80%688M | -27.64%466M | -24.22%485M | -14.70%528M |
Total non current assets | 2.36%39.94B | 2.36%39.94B | 2.60%39.49B | 2.29%39.18B | 2.89%39.22B | 2.52%39.02B | 2.52%39.02B | 1.47%38.49B | 1.93%38.31B | 3.89%38.12B |
Total assets | 0.84%42.76B | 0.84%42.76B | 2.91%43.07B | 2.78%42.36B | 2.93%42.7B | 1.18%42.41B | 1.18%42.41B | -0.93%41.85B | 2.11%41.22B | 2.54%41.48B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | ---- | ---- | 7.34%2.15B | 4.88%1.78B | 7.46%2.08B | 16.99%2.28B | 16.99%2.28B | -1.57%2B | -7.96%1.7B | -1.28%1.93B |
-accounts payable | ---- | ---- | 8.33%1.3B | 6.43%1.19B | 8.56%1.31B | 9.47%1.24B | 9.47%1.24B | 4.25%1.2B | 6.16%1.12B | 14.57%1.2B |
-Total tax payable | ---- | ---- | 4.99%379M | -10.29%122M | 5.82%382M | 372.97%525M | 372.97%525M | 131.41%361M | -23.16%136M | 0.56%361M |
-Other payable | ---- | ---- | 6.58%470M | 5.63%469M | 5.45%387M | -26.87%517M | -26.87%517M | -39.34%441M | -27.80%444M | -32.91%367M |
Current provisions | ---- | ---- | 10.53%147M | 7.25%148M | -7.28%140M | 0.00%144M | 0.00%144M | 17.70%133M | 22.12%138M | 27.97%151M |
Current debt and capital lease obligation | 8.60%606M | 8.60%606M | -98.93%6M | 5,470.00%557M | 4,963.64%557M | 269.54%558M | 269.54%558M | 260.65%559M | -95.76%10M | -96.53%11M |
-Current debt | 8.60%606M | 8.60%606M | -98.93%6M | 5,470.00%557M | 4,963.64%557M | 269.54%558M | 269.54%558M | 260.65%559M | -95.76%10M | -96.53%11M |
Other current liabilities | 998.77%2.67B | 998.77%2.67B | 11.30%266M | 21.26%251M | 10.53%252M | 6.58%243M | 6.58%243M | 16.59%239M | 5.08%207M | 23.91%228M |
Current liabilities | 1.61%3.28B | 1.61%3.28B | -12.44%2.57B | 33.28%2.74B | 30.29%3.02B | 30.47%3.22B | 30.47%3.22B | 16.99%2.93B | -14.12%2.06B | -9.86%2.32B |
Non current liabilities | ||||||||||
Long term provisions | ---- | ---- | 2.32%309M | 0.00%299M | 7.32%308M | 1.37%296M | 1.37%296M | -4.73%302M | 3.10%299M | 7.49%287M |
Long term debt and capital lease obligation | -3.08%17.9B | -3.08%17.9B | 3.47%19.03B | 0.37%18.45B | 0.30%18.45B | 0.45%18.47B | 0.45%18.47B | 0.04%18.39B | 11.77%18.38B | 11.48%18.39B |
-Long term debt | -0.43%17.9B | -0.43%17.9B | 3.53%18.54B | 0.30%17.95B | 0.18%17.94B | 0.44%17.98B | 0.44%17.98B | 0.04%17.9B | 12.04%17.9B | 11.81%17.91B |
-Long term capital lease obligation | ---- | ---- | 1.44%494M | 3.09%500M | 4.81%501M | 0.61%491M | 0.61%491M | 0.00%487M | 2.54%485M | 0.42%478M |
Non current deferred liabilities | -0.27%7.73B | -0.27%7.73B | 0.27%7.72B | 0.70%7.72B | 2.02%7.76B | 2.34%7.75B | 2.34%7.75B | 0.89%7.7B | 0.92%7.66B | 2.38%7.61B |
Other non current liabilities | 150.28%1.36B | 150.28%1.36B | -11.40%505M | -1.29%537M | 2.77%557M | -4.90%543M | -4.90%543M | 9.62%570M | 8.15%544M | 10.16%542M |
Total non current liabilities | -0.26%26.98B | -0.26%26.98B | 2.23%27.56B | 0.43%27B | 0.92%27.07B | 0.88%27.05B | 0.88%27.05B | 0.41%26.96B | 8.28%26.89B | 8.67%26.82B |
Total liabilities | -0.06%30.26B | -0.06%30.26B | 0.79%30.13B | 2.76%29.74B | 3.26%30.09B | 3.37%30.28B | 3.37%30.28B | 1.83%29.9B | 6.31%28.94B | 6.92%29.14B |
Shareholders'equity | ||||||||||
Share capital | ---- | ---- | -2.43%1.93B | -3.34%1.94B | -3.84%1.96B | -5.18%1.96B | -5.18%1.96B | -5.99%1.98B | -6.31%2.01B | -6.49%2.03B |
-common stock | ---- | ---- | -2.43%1.93B | -3.34%1.94B | -3.84%1.96B | -5.18%1.96B | -5.18%1.96B | -5.99%1.98B | -6.31%2.01B | -6.49%2.03B |
Retained earnings | ---- | ---- | 7.93%10.46B | 1.59%10.19B | 1.12%10.21B | -5.53%9.79B | -5.53%9.79B | -8.05%9.69B | -7.08%10.03B | -10.56%10.09B |
Paid-in capital | ---- | ---- | 24.05%815M | 21.47%758M | 26.58%743M | 20.38%691M | 20.38%691M | 18.38%657M | 16.85%624M | 469.90%587M |
Gains losses not affecting retained earnings | ---- | ---- | 27.69%-269M | 30.77%-270M | 20.73%-306M | 19.59%-312M | 19.59%-312M | -16.25%-372M | -15.38%-390M | -2.39%-386M |
Total stockholders'equity | 3.13%12.51B | 3.13%12.51B | 8.21%12.93B | 2.82%12.62B | 2.20%12.6B | -3.86%12.13B | -3.86%12.13B | -7.18%11.95B | -6.56%12.27B | -6.51%12.33B |
Noncontrolling interests | ---- | ---- | 25.00%5M | 0.00%4M | -37.50%5M | -50.00%5M | -50.00%5M | -55.56%4M | -60.00%4M | -27.27%8M |
Total equity | 3.08%12.51B | 3.08%12.51B | 8.21%12.94B | 2.82%12.62B | 2.17%12.6B | -3.90%12.13B | -3.90%12.13B | -7.21%11.95B | -6.60%12.27B | -6.53%12.33B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |